deferoxamine has been researched along with Paraplegia in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Paraplegia: Severe or complete loss of motor function in the lower extremities and lower portions of the trunk. This condition is most often associated with SPINAL CORD DISEASES, although BRAIN DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; and MUSCULAR DISEASES may also cause bilateral leg weakness.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qayumi, AK | 2 |
| Janusz, MT | 2 |
| Dorovini-Zis, K | 1 |
| Lyster, DM | 2 |
| Jamieson, WR | 2 |
| Poostizadeh, A | 1 |
| Feeley, EJ | 1 |
| Nikbakht-Sangari, M | 1 |
2 other studies available for deferoxamine and Paraplegia
| Article | Year |
|---|---|
Additive effect of allopurinol and deferoxamine in the prevention of spinal cord injury caused by aortic crossclamping.
Topics: Allopurinol; Animals; Aorta, Thoracic; Constriction; Deferoxamine; Drug Therapy, Combination; Female | 1994 |
Pharmacologic interventions for prevention of spinal cord injury caused by aortic crossclamping.
Topics: Allopurinol; Animals; Aorta; Aortic Aneurysm; Constriction; Deferoxamine; Free Radicals; Paraplegia; | 1992 |